Olivier Lechien

Corporate Communication Director at Ion Beam Applications SA

Olivier Lechien has more than 27 years of experience in various roles in corporate communication, public relations, and marketing. Olivier is currently serving as the Corporate Communication Director at IBA since January 2021. Previously, Olivier has held key positions such as Managing Director and Owner at Ellocom, Head of Public Relations at Lampiris, PR Director (Europe) at GSMA, and Head of Communications at the Cabinet of the Brussels Minister for Economy, Employment, Commerce, Health, and Scientific Research. Olivier has also served as Managing Director at Grayling Brussels, Corporate Communication Manager at Mobistar, and External Relations & Development Manager at Intermarché. Olivier started their career as an Account Director at Weber Shandwick and later became the Marketing & Communications Director at Deloitte.

Olivier Lechien has a Bachelor's degree in Law from UCLouvain Saint-Louis Bruxelles, which they obtained from 1986 to 1989. Olivier also holds a Master's degree in Corporate Communication from Université catholique de Louvain, earned from 1990 to 1992. In 1992-1993, they pursued a Postgraduate degree in Financial Communication from Université catholique de Louvain. Recently, in 2023, they completed the Senior Leadership Programme in Business Administration and Management from Vlerick Business School.

Location

Ottignies-Louvain-la-Neuve, Belgium

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Ion Beam Applications SA

4 followers

Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.


Employees

1,001-5,000

Links